The DOI matches its Crossref record; 53 of the 55 references it cites were found in a registry or an index.
Efficacy of Paroxetine in the Treatment of Adolescent Major Depression: A Randomized, Controlled Trial
Open accessAbstract
Objective To compare paroxetine with placebo and imipramine with placebo for the treatment of adolescent depression.Method After a 7- to 14-day screening period, 275 adolescents with major depression began 8 weeks of double-blind paroxetine (20-40 mg), imipramine (gradual upward titration to 200-300 mg), or placebo. The two primary outcome measures were endpoint response (Hamilton Rating Scale for Depression [HAM-D] score < or = 8 or > or = 50% reduction in baseline HAM-D) and change from baseline HAM-D score. Other depression-related variables were (1) HAM-D depressed mood item; (2) depression item of the Schedule for Affective Disorders and Schizophrenia for Adolescents-Lifetime version (K-SADS-L); (3) Clinical Global Impression (CGI) improvement scores of 1 or 2; (4) nine-item depression subscale of K-SADS-L; and (5) mean CGI improvement scores.Results Paroxetine demonstrated significantly greater improvement compared with placebo in HAM-D total score < or = 8, HAM-D depressed mood item, K-SADS-L depressed mood item, and CGI score of 1 or 2. The response to imipramine was not significantly different from placebo for any measure. Neither paroxetine nor imipramine differed significantly from placebo on parent- or self-rating measures. Withdrawal rates for adverse effects were 9.7% and 6.9% for paroxetine and placebo, respectively. Of 31.5% of subjects stopping imipramine therapy because of adverse effects, nearly one third did so because of adverse cardiovascular effects.Conclusions Paroxetine is generally well tolerated and effective for major depression in adolescents.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Initial trials with tricyclic antidepressants have not been replicated (50).”
From Pediatric psychopharmacology: Too much or too little? (2013) · cites this paper as [50]
In the citing paper
“Fifth, the Restoring Study 329, 39 which reanalysed the data and protocol of SmithKline Beecham's Study 329, 40 showed different and even opposite results of efficacy and tolerability of paroxetine and imipramine.”
Citations
Cites
Kessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370
A Diagnostic Interview: The Schedule for Affective Disorders and Schizophrenia
Endicott, J. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770310043002 · Cited by 5,684
The Sickness Impact Profile: Development and Final Revision of a Health Status Measure
Bergner, M., Bobbitt, R. A., Carter, W. B., & Gilson, B. S. (1981) · Medical Care · doi:10.1097/00005650-198108000-00001 · Cited by 4,619
Emslie, G. J. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830230069010 · Cited by 985
Self-citationDepressed Adolescents Grown Up
Weissman, M. M. (1999) · JAMA · doi:10.1001/jama.281.18.1707 · Cited by 952
Kessler, R. C., & Walters, E. E. (1998) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1998)7:1<3::aid-da2>3.0.co;2-f · Cited by 780
Textbook of psychopharmacology
Edwards, G. (1975) · Nature · doi:10.1038/258648b0 · Cited by 585
Unipolar Depression in Adolescents: Clinical Outcome in Adulthood
RAO, U., RYAN, N. D., BIRMAHER, B., DAHL, R. E., WILLIAMSON, D. E., KAUFMAN, J., RAO, R., & NELSON, B. (1995) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199505000-00009 · Cited by 514
Self-citationSuicidal Behaviors and Childhood-Onset Depressive Disorders: A Longitudinal Investigation
KOVACS, M., GOLDSTON, D., & GATSONIS, C. (1993) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199301000-00003 · Cited by 389
Efficacy of tricyclic drugs in treating child and adolescent depression: a meta-analysis
Hazell, P., O'Connell, D., Heathcote, D., Robertson, J., & Henry, D. (1995) · BMJ · doi:10.1136/bmj.310.6984.897 · Cited by 308
Research works printed but not linked: 2
- Fawcett, 1987, Clinical management: imipramine/placebo administration manual, Psychopharmacol Bull, 23, 309
- Rodriguez-Ramos, 1996, Effects of paroxetine in depressed adolescents, Eur J Clin Res, 8, 49
Cited by
Youth Suicide Risk and Preventive Interventions: A Review of the Past 10 Years
GOULD, M. S., GREENBERG, T., VELTING, D. M., & SHAFFER, D. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000046821.95464.cf · Cited by 1,264
“SSRIs have been shown to be more effective than placebo in treating depressed teenagers (Emslie and Mayes, 2001; Emslie et al., 1997; Keller et al., 2001), they are consid- erably less dangerous in overdose than are tricyclic antidepressants (Ryan and Varma, 1998), and there is evidence that they…”
BackgroundBridge, J. A., Iyengar, S., Salary, C. B., Barbe, R. P., Birmaher, B., Pincus, H. A., Ren, L., & Brent, D. A. (2007) · JAMA · doi:10.1001/jama.297.15.1683 · Cited by 1,086
Self-citationWhittington, C. J., Kendall, T., Fonagy, P., Cottrell, D., Cotgrove, A., & Boddington, E. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16043-1 · Cited by 1,058
Cipriani, A., Zhou, X., Del Giovane, C., Hetrick, S. E., Qin, B., Whittington, C., Coghill, D., Zhang, Y., Hazell, P., Leucht, S., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30385-3 · Cited by 734
Antidepressants and the Risk of Suicidal Behaviors
Jick, H. (2004) · JAMA · doi:10.1001/jama.292.3.338 · Cited by 578
Metadata
- Authors
- KELLER, M. B., RYAN, N. D., STROBER, M., KLEIN, R. G., KUTCHER, S. P., BIRMAHER, B., HAGINO, O. R., KOPLEWICZ, H., CARLSON, G. A., CLARKE, G. N., EMSLIE, G. J., FEINBERG, D., GELLER, B., KUSUMAKAR, V., PAPATHEODOROU, G., SACK, W. H., SWEENEY, M., WAGNER, K. D., WELLER, E. B., WINTERS, N. C., OAKES, R., & MCCAFFERTY, J. P.
- Affiliations
- Brown University (US)
- Corresponding author
- KELLER, MARTIN B.
- ORCID
- Venue
- Journal of the American Academy of Child & Adolescent Psychiatry
- Publisher
- Elsevier BV
- Published
- 2001-07
- Volume
- 40
- Issue
- 7
- Pages
- 762-772
- ISSN
- 0890-8567 (ISSN-L)
- OpenAlex
- W2162865096
- Cited by
- 641
- References
- 55
- Citations by year
- 2026: 12 · 2025: 9 · 2024: 11 · 2023: 12 · 2022: 13 · 2021: 11 · 2020: 17 · 2019: 19 · 2018: 15 · 2017: 13 · 2016: 23 · 2015: 17 · 2014: 16 · 2013: 20 · 2012: 23
- FWCI
- 37.72
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Journal of the American Academy of Child & Adolescent Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (U01MH062014)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Clinical Psychology › Psychological Treatments and Disorders
- Keywords
- paroxetine, imipramine, adolescent depression, major depressive disorder, antidepressant efficacy, adverse drug reactions, cardiovascular adverse events, treatment withdrawal, self-rated depression
- MeSH terms
- Adolescent, Analysis of Variance, Antidepressive Agents, Tricyclic, Depressive Disorder, Dose-Response Relationship, Drug, Double-Blind Method, Female, Humans, Imipramine, Male, Least-Squares Analysis, Selective Serotonin Reuptake Inhibitors, Paroxetine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy of Paroxetine in the Treatment of Adolescent Major Depression: A Randomized, Controlled Trial. https://app.cochat.ai/papers/10.1097/00004583-200107000-00010
- The paper
- KELLER, M. B., RYAN, N. D., STROBER, M., KLEIN, R. G., KUTCHER, S. P., BIRMAHER, B., HAGINO, O. R., KOPLEWICZ, H., CARLSON, G. A., CLARKE, G. N., EMSLIE, G. J., FEINBERG, D., GELLER, B., KUSUMAKAR, V., PAPATHEODOROU, G., SACK, W. H., SWEENEY, M., WAGNER, K. D., WELLER, E. B., . . . MCCAFFERTY, J. P. (2001). Efficacy of Paroxetine in the Treatment of Adolescent Major Depression: A Randomized, Controlled Trial. Journal of the American Academy of Child & Adolescent Psychiatry. https://doi.org/10.1097/00004583-200107000-00010
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.